Skip to content

Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)

Active, not recruitingPhase 3NCT04874038
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

Brief summary (from the registry)

Phase III, international multicentre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of an intraoperative intravenous lidocaine infusion on reducing the development of persistent pain 3-months after breast cancer surgery.

Study details

Official title
Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)
Conditions
Interventions
Sponsor
University Health Network, Toronto
Collaborators
Canadian Institutes of Health Research (CIHR)
Start date
2021-09-22
Primary completion
2026-04-30
Sex
All
Age range
from 18 Years to 100 Years
Results posted
No results posted in this snapshot
Countries
Canada, Nepal, Nigeria
Total sites listed
17

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Age ≥18 years old 2. Undergoing a unilateral or bilateral lumpectomy or mastectomy, inclusive of all pathologies, including prophylactic surgery (e.g., family history or BRCA gene mutation) Exclusion Criteria: 1. Previous breast surgery within 6 months of index surgery 2. Undergoing any autologous flap procedure during index surgery 3. Presence known chronic pain disorder involving surgical site or ipsilateral chest wall, shoulder, or arm during the 3-months prior to index surgery 4. Documented hypersensitivity or allergy to lidocaine 5. Surgery not planned to be performed under general anesthesia and/or planned use of regional or neuraxial anesthetic techniques before surgery (i.e., epidural, paravertebral, serratus plane block, pectoralis or modified pectoralis block) 6. History of ventricular tachycardia, ventricular fibrillation, or atrioventricular block without a pacemaker 7. Known cirrhotic liver disease 8. Pregnant 9. Unlikely to comply with follow-up (e.g. no fixed address, language difficulties that would impede valid completion of questionnaires, plans to move out of town)

Canadian sites (15)

FacilityCityProvince
Foothills Medical CentreCalgaryAlberta
Sturgeon Community HospitalEdmontonAlberta
Eastern Health- Health Sciences CentreSt. John'sNewfoundland and Labrador
IWKHalifaxNova Scotia
Juravinski HospitalHamiltonOntario
North York General HospitalNorth YorkOntario
The Ottawa HospitalOttawaOntario
Thunder Bay Regional Health Sciences CentreThunder BayOntario
Humber River HospitalTorontoOntario
Mount Sinai HospitalTorontoOntario
St. Michael's HospitalTorontoOntario
Sunnybrook Health Sciences CentreTorontoOntario
University Health NetworkTorontoOntario
Women's College HospitalTorontoOntario
Hôpital Maisonneuve-RosemontMontrealQuebec
Canadian sites for NCT04874038CalgaryEdmontonSt. John'sHalifaxHamiltonOttawaThunder BayToronto
Canadian sites for NCT04874038. 9 mapped locations with coordinates in the registry. Schematic plot, not to scale.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04874038